Role of ROS‑mediated autophagy in melanoma (Review)

Mol Med Rep. 2022 Oct;26(4):303. doi: 10.3892/mmr.2022.12819. Epub 2022 Aug 10.

Abstract

Melanoma is the most aggressive form of skin cancer with the poorest prognosis and its pathogenesis has yet to be fully elucidated. As key factors that regulate cellular homeostasis, both reactive oxygen species (ROS) and autophagy are involved in the development of melanoma, from melanomagenesis to progression and drug resistance. However, the interaction between ROS and autophagy in the etiology and treatment of melanoma is not well characterized. The present review examined the production of ROS and the role of oxidative stress in melanoma, and summarized the role of ROS‑mediated autophagy in melanomagenesis and melanoma cell fate decision following treatment with various anticancer drugs. The present findings may lead to a better understanding of the pathogenesis and progression of melanoma, and suggest promising treatment options for this disease.

Keywords: autophagy; melanoma; melanomagenesis; oxidative stress; reactive oxygen species.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Autophagy
  • Humans
  • Melanoma* / pathology
  • Oxidative Stress
  • Reactive Oxygen Species

Substances

  • Antineoplastic Agents
  • Reactive Oxygen Species

Grants and funding

The present study was funded by the Traditional Chinese Medicine research projects of Heilongjiang Province (grant no. ZHY2020-041) and the Doctoral Program of Heilongjiang Province (grant no. LBH-Z21218).